Patent details

Basic Information

Publication number:

EP1077912

PCT Application Number:

PCT/EP/99/03212

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP999249295

PCT Publication Number:

WO/99/58478

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES

French Title of Invention:

NOUVEAUX DERIVES DE 3,3-DIPHENYLPROPYLAMINES

German Title of Invention:

3,3-DIPHENYLPROPYLAMINDERIVATE

SPC Number:

91365

Dates

Filing date:

11/05/1999

Grant date:

03/07/2002

EP Publication Date:

03/07/2002

PCT Publication Date:

18/11/1999

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/02/2001

EP B1 Publication Date:

03/07/2002

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

11/05/2019

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

30/08/2017

 

 

Name:

UCB Pharma GmbH

Address:

Alfred-Nobel-Strasse 10, 40789 Monheim, Germany (DE)

History of Owners

From:

11/05/1999

To:

30/08/2017

Name:

SCHWARZ PHARMA AG

Address:

Alfred-Nobel-Strasse 10, D-40789 Monheim/Rhld., Germany (DE)

Agent

Name:

WAXWEILER Jean

From:

19/07/2002

Address:

PO Box 1502, 1015, Luxembourg, Luxembourg (LU)

To:

Inventor

1

Name:

MEESE Claus

Address:

Germany (DE)

2

Name:

SPARF Bengt

Address:

Sweden (SE)

Licencee

Name:

Pfizer Inc.

From:

30/08/2017

Address:

235 East 42nd Street, New York, NY 10017, United States (US)

To:

Priority

Priority Number:

98108608

Priority Date:

12/05/1998

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

C07C 1/00;

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2017/05

Publication date:

13/09/2017

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

MED

Bulletin edition number:

2017/06

Publication date:

10/10/2017

Description:

Section K : Modifications and recordals into the register

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20170000323A

Date Registered:

30/08/2017

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

Office FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

UCB Pharma GmbH

Address:

Alfred-Nobel-Strasse 10, 40789 Monheim, Germany (DE)

Removed Pledgee

Name:

Address:

Licence

Change Kind/ Decision Type:

New licence registration

Deed Number:

RC20170000324A

Date Registered:

30/08/2017

Licence Effective Date:

05/01/2017

Licence Expiration Date:

Scope of Licence:

Exclusive

Deed Filer:

Office FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Licencee(s)

Name:

Pfizer Inc.

Address:

235 East 42nd Street, New York, NY 10017, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

24/04/2018

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages
31/08/2017	Outgoing Correspondence	1
07/09/2017	Outgoing Correspondence	1
30/08/2017	Request For Change	4
30/08/2017	Request For Change	1